Spinal Elements, Inc.
$1.3M 850 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Mayne Pharma Commercial LLC
Mayne Pharma Commercial LLC reported $1,330,371.30 across General Payments, Research, and Ownership to 29,072 physicians and teaching hospitals across 29,072 transactions.
- $1.3M
- All-tracks total
- 29,072
- Transactions
- 29,072
- Recipients
- −$589.6K
- General Payments vs PY2023
Mayne Pharma Commercial LLC reported $1,330,371.30 across all CMS Open Payments tracks (General + Research + Ownership) to 29,072 physicians and teaching hospitals in Program Year 2024 - ranking #553 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,330,371.30, averaging $45.76 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer mayne-pharma-commercial-llc Mayne Pharma Commercial LLC
$1.3M · #553/1,925 · 0.0% industry · PY2024
- TOT $1.3M
- RANK #553
- SHARE 0.0%
- TXN 29,072
- RCP 29,072
- CAT 4
- GEN $1.3M
- ΔGEN −$589.6K
- TOP1 8.0%
- PY 2024
Volume peers
Nearest volume peer: Spinal Elements, Inc. ($1.3M)
Mayne Pharma Commercial LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Mayne Pharma Commercial LLC's CMS-reported General Payments decreased by $589.6K (−30.7%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: MAYNE PHARMA COMMERCIAL LLCPY2023: MAYNE PHARMA COMMERCIAL LLCPY2024: MAYNE PHARMA COMMERCIAL LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $1,919,974.98
- PY2024
- $1,330,371.30
What the Data Shows for Mayne Pharma Commercial LLC
Averaging $45.76 per transaction and $45.76 per recipient, Mayne Pharma Commercial LLC's Program Year 2024 total comes to $1,330,371.30 across 29,072 transactions and 29,072 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #553 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
"Food and Beverage" leads the 4-category general-payment breakdown below at $567.9K (42.7% of General Payments, 28,720 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Mayne Pharma Commercial LLC made 4 types of general payments. "Food and Beverage" is the largest category at $567.9K, 42.7% of General Payments.
Mayne Pharma Commercial LLC reports 4 general-payment categories - the top three are Food and Beverage (42.7%), Compensation for Services Other Than Consulting (42.6%), and Honoraria (8.7%). The remaining 1 category make up 6.0% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Mayne Pharma Commercial LLC divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $567.9K | 28,720 | 42.7% |
| Compensation for Services Other Than Consulting | $567.3K | 121 | 42.6% |
| Honoraria | $115.2K | 47 | 8.7% |
| Travel and Lodging | $80.0K | 184 | 6.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $438,961.06 (33.0%) of $1,330,371.30 in this company's General Payments records across 8,796 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Mayne Pharma Commercial LLC
The five named recipients with the highest reported General Payments from this company
- 1
Elliot Cazes
$106,575.73 across 86 reported transactions
- 2
James Simon
$103,641.66 across 73 reported transactions
- 3
Anita Nelson
$91,806.26 across 52 reported transactions
- 4
Jay Cohen
$80,062.44 across 72 reported transactions
- 5
Andrew London
$56,874.97 across 46 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Mayne Pharma Commercial LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Mayne Pharma Commercial LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Mayne Pharma Commercial LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Ironshore Pharmaceuticals Inc.
$1.3M 45,495 recipients
Compare payment profiles
Sight Sciences, Inc.
$1.3M 7,583 recipients
Compare payment profiles
C. R. Bard, Inc. & Subsidiaries
$1.3M 2,216 recipients
Compare payment profiles
Surmodics, Inc.
$1.3M 2,433 recipients
Compare payment profiles
Leadiant Biosciences, Inc.
$1.3M 65 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.